SKINNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
SkinHealth Systems Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$10.55−0.01 (-0.09%)
Close on Oct 19, 2026
- Market cap
- $1.37B
- P/E (TTM)
- –
- Dividend yield
- –
SkinHealth Systems Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 66.4%
- Operating margin
- -1.5%
- Net margin
- -9.8%
- Return on equity, FY2025
- -16.9%
Financial strength
- Current ratio
- 1.76
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 122.5%
Valuation
- P/E ratio
- –
- Price to sales
- 4.71
- Price to book
- 24.60
- Dividend yield
- –